MARKET IS CLOSED
Loading latest tickers...

Market Indices

S&P 500
$7,666.45
+0.19%
NASDAQ 100
$30,501.56
+0.31%
DOW JONES
$50,927.00
+0.04%
NASDAQ Composite
$26,871.60
+0.04%
RUSSELL 2000
$2,790.20
+0.41%
CBOE VIX
$16.39
+0.31%

Sector Heatmap

Technology+1.05%
Financials+0.11%
Healthcare-1.32%
Consumer Cycl-0.03%
Consumer Staples-0.33%
Energy+1.95%
Industrials+0.99%
Materials-0.33%
Real Estate-0.56%
Utilities+0.61%
Comm Services-0.93%

DGX — Quest Diagnostics Inc.

NYSE

Quest Diagnostics Inc.

Back to Screener
$231.09
-1.98(-0.85%)
O
232.74
H
233.33
L
230.47
V
990.28K
⏱️ End-of-day dataAs of Oct 1, 2026

Chart

About DGX

Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the US. The company generates over 97% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,400 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.

IndustrySERVICES-MEDICAL LABORATORIES
SectorNot available
IPO DateDec 17, 1996
Employees57,000
Stock ExchangeNYSE
Ticker SymbolDGX

Key Financial Statistics

Market Cap$26.08B
P/E RatioN/A
Dividend YieldN/A
EPSN/A
BetaN/A
52-Week Range$3.31 - $248.84
52-Week Avg Volume1.25M
VWAP$231.65
Transactions22,812
Total Recorded Bars7,493 days